Sentences with phrase «biomedical research policy»

Thus far, much of the conversation about postdocs and their roles in the scientific workforce has been enmeshed in wider discussions of biomedical research policy [9,10].

More recently, she took on biomedical research policy and the National Institutes of Health.

Not exact matches

Evolution was not correctly taught if you believe that it is a belief or a mere theory in the colloquial sense, that it unnecessarily complicates the world, and that understanding how organisms change over time is not crucial for environmental policy, agriculture and biomedical research.

On January 18, AAAS reaffirmed its support for the current public access policy of the U.S. National Institutes of Health (NIH), stating that it does not endorse the Research Works Act, which would prevent NIH from requiring its grantees to make biomedical research findings freely available via the National Library of Medicine's WResearch Works Act, which would prevent NIH from requiring its grantees to make biomedical research findings freely available via the National Library of Medicine's Wresearch findings freely available via the National Library of Medicine's Web site.

Sam Kean Contributing Correspondent Writes about biomedicine and biomedical research, and science policy.

I work in the Science Policy Department of the Centro Nacional de Investigaciones Cardiovasculares (CNIC), the Spanish national centre for cardiovascular research, which was established by the Spanish ministry of health as a centre of excellence to give impetus to biomedical research in this area.

She now focuses on stories about biomedical research and policy.

«We're at a remarkable moment in biomedical research and its potential for making advances,» said Collins during a March 27 presentation on federal agency priorities on the opening day of the 42nd AAAS Science & Technology Policy Forum held at the Ronald Reagan Building in Washington.

«With the rise of new and unproven stem cell treatments, the NFL faces a daunting task of trying to better understand and regulate the use of these therapies in order to protect the health of its players,» said Kirstin Matthews, the Baker Institute fellow in science and technology policy and an expert on ethical and policy issues related to biomedical research and development.

Dr. Frankel is currently directing or co-directing projects related to the ethical and policy implications of human germ - line interventions, the responsible use of animals in biomedical and behavioral research, improving patient safety and reducing errors in health care, the ethical dimensions of the Human Genome Diversity Project, the uses of anonymity on the Internet, and intellectual property and ethical standards for electronic publishing in science.

Bioethicists have said that they expect the new commission to be more policy - oriented and pragmatic than its predecessor, which focused largely on philosophical and moral issues involved in biomedical research.

Since policy issues are influenced by scientists, I am indeed passionate about the need for the biomedical research community to be vigilant in its responsibility to correctly interpret and communicate its findings.

«Today, the role of patients as partners permeates the R&D landscape,» and «[t] he past year has ushered in a «perfect storm» of policy initiatives in biomedical research and opportunities for patient engagement,» the authors wrote.

While he has offered few details on policies for biomedical research, Trump said last year that he has heard «terrible» things about the US National Institutes of Health; he has also derided NASA as a «logistics agency for low - Earth orbit activity ``, and said he would expand the role of the commercial space industry in the US space programme.

Some biomedical research watchers are feeling blindsided by a federal appeals court decision last week that reversed a lower court's rejection of a lawsuit challenging the Obama Administration's stem cell policy.

The NIH has not funded new research involving chimps since December 2011, when the Institute of Medicine, a nonprofit that advises the government on health policy, issued a report establishing strict criteria for the use of chimps in biomedical and behavioral research.

In a major policy shift that is reverberating across the biomedical research community, the National Institutes of Health (NIH) in Bethesda, Maryland, says it plans to cap the number of grants an investigator can hold in order to free up funding for early - career scientists and those struggling to keep their labs afloat.

To the biomedical research community, she was refreshingly «frank and open,» says Tony Mazzaschi, senior director for policy and research at the Association of Schools and Programs of Public Health in Washington, D.C. «She will be sorely missed.»

Policy goes further than most biomedical research funding agencies» requirements by dispensing with embargo period

► In a policy forum in this week's STM, four physician scientists expressed concern that a recent «shift toward new models of medical education in which research plays a minimal role... threatens the quality of education received by our future biomedical workforce as well as the pipeline of physician - scientists — important consequences that have received little attention.»

As UCSF's first vice chancellor for science policy and strategy, Keith Yamamoto leads efforts to anticipate the needs of an increasingly dynamic biomedical research endeavor, and to position UCSF optimally, by working within the university as well as influencing and shaping science policy at the state and national levels and beyond.

In this position she is using her research expertise in biomedical and biophysical chemistry and her analytical skills to help address the nation's problems while learning about federal policy making.

They will include research and analysis on a wide range of policy issues impacting biomedical research and its clinical application, and summarizing those analyses for different audiences.

SEATTLE — Supercomputing's roles in biomedical research and policy making will be discussed by U.S. Department of Energy chief scientist Dimitri Kusnezov at 4 p.m. Tuesday, Sept. 20, at the Allen Institute in Seattle.

The ACD advises the NIH Director on policy matters important to the NIH mission of conducting and supporting biomedical and behavioral research, research training, and translating research results for the public.

• Minimum of 8 - 10 years in scientific policy / health policy within pharmaceutical sector, Government or biomedical community (e.g. research funders, think - tank or regulators).

Meg assists biomedical research and policy groups write persuasively about their work to professional and lay audiences in order to help them achieve their professional goals.